Navidea Biopharmaceuticals Inc Business Update Financing Call Transcript

Apr 14, 2022 / 09:00PM GMT
Operator

Greetings. Welcome to the Navidea Business Update Finance conference call. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to your host, Michael Rosol, Navidea's Chief Medical Officer. You may begin.

Michael Stanley Rosol - Navidea Biopharmaceuticals, Inc. - Senior VP & Chief Medical Officer

Thank you, and thank you all for joining us here today on this business update Q&A session. This call is being webcast live on our website, ir.navidea.com, and a replay will be made available. Following prepared remarks, we will be conducting an open question-and-answer segment focused on our financing that will be moderated by me, Mike Rosol and including the Chair of our Board of Directors, Mr. Alex Cappello, joined by our Vice Chair of the Board, Mr. Kim Scott. My colleague, Erika Eves, our VP of Finance and Administration, is also joining me here today in Dublin.

During the course of this conference call, we will be making forward-looking statements regarding future events and the future

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot